期刊： INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021; 36 (5)
Parkinson's disease (PD) is a neurological disorder involving both motor and nonmotor symptoms. Multimorbidity acts synergistically to heighten the ri......
期刊： INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021; 36 (3)
Children and adolescents with ASD also have co-occurrence of attention deficit hyperactivity disorder (ADHD) symptoms. ADHD symptoms, especially hyper......
期刊： INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021; 36 (4)
Pharmacological intervention played an important role in the management of tic disorder. Large-scale prescription data for pediatric tic disorder pati......
期刊： INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021; 36 (3)
The aim of the study was to conduct a multicenter randomized double-blinded placebo-controlled clinical study to evaluate the efficacy of a generic fo......
期刊： INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021; 36 (5)
We aimed to investigate the effects of infection on serum concentrations of different antipsychotics in inpatients with respiratory tract infections t......
期刊： INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021; 36 (3)
Poststroke depression (PSD) is the most frequent complication after stroke. Statin is a widely used prophylactic for stroke. However, some researchers......
期刊： INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2020; 35 (6)
Hallucinations are important diagnostic symptoms in schizophrenia, but also occur in other medical and neuropsychiatric conditions. Not all patients w......
期刊： INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2020; 35 (1)
Traditional medicines in the form of health food and supplements are highly popular nowadays. They are often aggressively promoted with unsubstantiate......
期刊： INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2020; 35 (2)
Attention deficit hyperactivity disorder (ADHD) is a multifactorial neurodevelopmental disorder that manifests during childhood. Methylphenidate (MPH)......
期刊： INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2019; 34 (6)
Alzheimer's disease is a devastating neurodegenerative disease that requires pharmacological intervention. We conducted a descriptive study using phar......
期刊： INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2019; 34 (1)
A new self-rating functional scale (SRFS) was developed to assess the functionality of patients with schizophrenia, referred to the structure of Perso......
期刊： INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2019; 34 (5)
Objective The aim of this study was to ensure patients' safety and to enhance treatment efficacy, knowledge about pharmacokinetic interactions even in......
期刊： INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2019; 34 (4)
This study aimed to assess the associations between the use of different types of antidepressants and health service utilization and costs among depre......
期刊： INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2018; 33 (2)
This pilot study examined the effect of adjunctive salsalate on psychopathology and cognition in patients with schizophrenia. This was a 12-week, open......
期刊： INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2018; 33 (3)
The objective of this study was to evaluate the prevalence and relative risk of off-label prescription of antidepressants in Chinese pediatric outpati......
